filmov
tv
TGFβ Activation and Inhibition | Science Animation
Показать описание
Peptide growth factors are central to the signalling between and among all cells in the body, and aberrations in such signalling underlie many disease processes. Traditional approaches treat growth factors much like circulating cytokines— to be inhibited systemically for therapeutic outcomes. However, many peptide growth factors are expressed by cells in latent forms that must first be activated in order to carry out their normal functions in a highly localized tissue microenvironment.
CONTENT
00:00 TGF-β Activation
01:20 TGF-β Inhibition
SOURCE
#biology #medical #microbiology
FOLLOW US
---------------------------------------------------
CONTENT
00:00 TGF-β Activation
01:20 TGF-β Inhibition
SOURCE
#biology #medical #microbiology
FOLLOW US
---------------------------------------------------
0:01:55
TGFβ Activation and Inhibition | Science Animation
0:06:01
TGF Beta Signalling Pathway
0:05:31
TGF-beta signaling
0:03:18
SB 431542: Unlocking Potential Therapies by Inhibiting TGF-β Signaling Pathway | GlpBio
0:09:29
TGF-Beta signaling pathway | Cell cycle and TGF beta pathway | TGF beta pathway in cancer
0:20:15
Ahmed: The guts of Wnt signal transduction.
0:02:10
Targeting TGF-β signaling in cancer
0:03:19
Mechanism of Action of SMAD7 Inhibitors
0:04:05
Video Synopsis: LITATS1 inhibits TGF-β-induced EMT (EMBO Journal)
0:50:14
Webinar: Modeling NAFLD and TGFbeta-induced Fibrosis in ExVive™ Human Liver Tissue
0:00:52
Nanovesicles loaded with a TGF-β receptor 1 inhibitor overcome immune resistance to p... | RTCL.TV
0:02:05
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
0:02:56
Structural basis of latent TGF-β1 presentation and activation by GARP on human regulatory T cells
0:01:36
Addition of an EGFR/TGFβ inhibitor with pembrolizumab in head and neck cancer
0:00:14
TGF beta signaling simplified
0:03:58
Video Synopsis: Gangliosides inhibit TGF-β-induced EMT (EMBO Journal)
0:07:19
Role for GARP-TGF-beta on B cells in immune tolerance
0:02:05
Mechanism of Action of PLN-74809 to Treat Idiopathic Pulmonary Fibrosis (IPF)
0:56:54
“TGF-β: An Emerging Therapeutic Target in Multiple Myeloma” by Ehsan Malek, MD
0:01:11
Pliant's Approach: The TGF-β Fibrosis Cascade
0:51:47
TGFβ in inherited vasculopathies - Hal Dietz
1:57:48
TRACO 2019 - TGF beta and Small molecules
0:05:03
Transforming growth factor beta(tgf ß) pathway and inhibition.
1:05:45
Blocking Cancer Progression and Shrinking Tumors with Antibody-ligand Traps
Комментарии